16.05.2019 16:17:12

DGAP-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

DGAP Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

16.05.2019 / 16:17
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed :

Report: Quarterly/ Interim statement within the 1st half-year Date of disclosure / German: May 21, 2019 Date of disclosure / English: May 21, 2019 German: https://ir.dermapharm.de/#Finanzberichte English: https://ir.dermapharm.de/index-EN.php#Finanzberichte



16.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News DGAP News Service

812551  16.05.2019 

fncls.ssp?fn=show_t_gif&application_id=812551&application_name=news&site_id=smarthouse

Analysen zu Dermapharm Holding SEmehr Analysen

05.12.24 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.11.24 Dermapharm Buy Jefferies & Company Inc.
15.11.24 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.11.24 Dermapharm Buy Jefferies & Company Inc.
06.09.24 Dermapharm Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Dermapharm Holding SE 37,75 0,00% Dermapharm Holding SE